Transcelerate Biopharma Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2012 | 5,672,849 | 5,494,217 | 178,632 | 0.4 | 0% |
| 2013 | 13,643,765 | 6,823,303 | 6,820,462 | 12.6 | 16% |
| 2014 | 15,293,388 | 11,780,323 | 3,513,065 | 10.3 | 17% |
| 2015 | 25,465,264 | 16,269,496 | 9,195,768 | 14.2 | 19% |
| 2016 | 20,679,184 | 23,733,704 | −3,054,520 | 8.2 | 14% |
| 2017 | 26,172,580 | 29,275,313 | −3,102,733 | 5.4 | 15% |
| 2018 | 25,318,445 | 30,891,037 | −5,572,592 | 2.9 | 15% |
| 2019 | 27,979,345 | 26,700,072 | 1,279,273 | 4.0 | 22% |
| 2020 | 31,974,894 | 28,107,965 | 3,866,929 | 5.4 | 24% |
| 2021 | 31,090,660 | 33,180,341 | −2,089,681 | 3.8 | 21% |
| 2022 | 33,600,302 | 34,262,372 | −662,070 | 3.5 | 23% |
| 2023 | 34,168,812 | 32,521,149 | 1,647,663 | 4.3 | 27% |
In its most recent public year (2023), this organization brought in $1,647,663 more than it spent. Its reserves stood at about 4.3 months of spending, up from 0.4 in 2012. Staff pay was 27% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works